New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 3, 2014
10:29 EDTSPPIFDA approves Beleodaq for treatment of patients with PTCL
The FDA approved Beleodaq for the treatment of patients with peripheral T-cell lymphoma, PTCL, a rare and fast-growing type of non-Hodgkin lymphoma (NHL). The action was taken under the agency’s accelerated approval program. Beleodaq and Folotyn are marketed by Spectrum Pharmaceuticals (SPPI).
News For SPPI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 19, 2014
10:00 EDTSPPIOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:07 EDTSPPISpectrum initiated with a Hold at Jefferies
Subscribe for More Information
07:09 EDTSPPIJefferies to hold a conference
2014 Global London Healthcare Conference is being held in London, England on November 19-20.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use